Veeva Systems Reports Strong FY26 Results, $180M Share Repurchase, and Ostro Acquisition Details
VEEV is trading near its 52-week low of $168.135 (9.5% above the low) on elevated volume (2.0× avg).
Summary
Veeva Systems reported strong fiscal year 2026 financial results, including 16% revenue growth and 27% net income growth, alongside the execution of a $180 million share repurchase and the formal disclosure of the strategic Ostro acquisition.
Key Events · Earnings and Guidance · VEEV
-
Strong Fiscal Year 2026 Financial Performance
Veeva Systems reported total revenues of $3.195 billion for fiscal year 2026, a 16% increase year-over-year. Net income grew by 27.3% to $908.9 million, and diluted EPS increased by 25.9% to $5.44.
-
$180 Million Share Repurchase Completed
The company repurchased 801,735 shares of common stock for approximately $180 million during the fiscal year ended January 31, 2026, under the $2 billion program authorized in January 2026. Approximately $1.82 billion remains available for future repurchases.
-
Strategic Acquisition of Ostro Confirmed
Veeva Systems formally disclosed the acquisition of Rise Healthcare Tech, Inc. ('Ostro') on March 10, 2026, for approximately $100 million in cash and long-term equity retention grants. Ostro provides an AI-driven chat engagement platform for life sciences.
-
Resolution of IQVIA Litigation
On August 13, 2025, Veeva and IQVIA entered into a settlement agreement, resolving all ongoing litigations without either party paying damages to the other. Veeva paid approximately $31 million to its law firms for contingency fees.
Analysis · VEEV · Technology
Veeva Systems delivered robust financial performance for fiscal year 2026, with significant growth in revenue, net income, and diluted EPS. The company also executed a substantial portion of its share repurchase program, returning capital to shareholders. The formal disclosure of the Ostro acquisition, a strategic move into AI-driven engagement platforms, confirms prior news with financial specifics. The resolution of long-standing litigation with IQVIA removes a key uncertainty, while the ongoing transition of Veeva CRM from the Salesforce platform to its own Vault CRM continues as a major strategic initiative.
How filings like this one have moved
In the 30 days to Sep 14, 2026, 35.8% of the 1045 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.43%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, VEEV was trading at $184.07 on NYSE in the Technology sector, with a market capitalization of approximately $30.3B. The 52-week trading range was $168.14 to $310.50. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.